The effect of tracheotomy on drug consumption in patients with acute aneurysmal subarachnoid hemorrhage: an observational study

BMC Anesthesiology

Leiv Arne Rosseland³  Jon Narum¹  Audun Stubhaug³  Ulf Kongsgaard³  Wilhelm Sorteberg²  Angelika Sorteberg² 

[1] Department of Anesthesiology, Division of Emergencies and Critical Care, Oslo University Hospital – Rikshospitalet, Oslo 0027, Norway

[2] Department of Neurosurgery, Oslo University Hospital – Rikshospitalet, Oslo, Norway

[3] Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

关键词: Dopamine;    Noradrenaline;    Fentanyl;    Midazolam;    Critical care;    Stroke;    Blood pressure;    Subarachnoid hemorrhage;    Tracheotomy;   

Others  :  1170514
DOI  :  10.1186/s12871-015-0029-5

 received in 2014-09-24, accepted in 2015-03-25,  发布年份 2015

【 摘 要 】

Background

Patients with aneurysmal subarachnoid hemorrhage (aSAH) are common in intensive care units (ICU). In patients with aSAH, sedation is used as a neuroprotective measure in order to secure adequate cerebral perfusion pressure (CPP). Compared with the use of an endotracheal tube, a tracheotomy has the advantage of securing the airway at a much lower level of distress, and aSAH patients can often be awakened more rapidly. Little is known about the impact of tracheotomy on the consumption of sedative/analgesic and vasoactive drugs and the maintenance of CPP within defined limits in aSAH patients.

Methods

We conducted an observational study of aSAH patients who underwent percutaneous tracheotomy. A prospective registry of patient data was supplemented with retrospective retrievals from medical records. Sedative, analgesic and vasoactive drug doses were registered for 3 days prior to and after percutaneous tracheotomy, respectively. Blood pressure, CPP, and the mode of mechanical ventilation were registered 24 h prior to and after tracheotomy.

Results

Between January 2001 and June 2009, 902 aSAH patients were admitted to our hospital; 74 (8%) were deeply comatose/dying upon arrival. The ruptured aneurysm was repaired in 828 patients (surgical repair 50%) and percutaneous tracheotomy was performed 182 times in 178 patients (59 men and 119 women). This subpopulation (178 of 828 patients) was significantly older (56 vs. 53 years) and presented with a more severe Hunt & Hess grade (p < 0.001). Percutaneous tracheotomy caused a marked decline in mean daily consumption of the analgesics/sedatives fentanyl, midazolam, and propofol, as well as the vasoactive drugs noradrenaline and dopamine. These declines were statistically and clinically significant. The mean CPP was 76 mmHg (SD 8.6) the day before and 79 mmHg (SD 9.6) 24 h after percutaneous tracheotomy. After percutaneous tracheotomy, mechanical ventilatory support could be reduced to a patient-controlled ventilatory support mode in a significant number of patients (p < 0.001).

Conclusions

Percutaneous tracheotomy in aSAH patients is a swift procedure with low risk that is associated with a significant decline in the consumption of sedative/analgesic and vasoactive drugs while clinical surveillance parameters remain stable or improve.

【 授权许可】

   
2015 Rosseland et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Von Elm E, Altman DG, Egger M, Pocock SJ, G°tzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457.
• [2]Rosseland LA, Laake JH, Stubhaug A: Percutaneous dilatational tracheotomy in intensive care unit patients with increased bleeding risk or obesity. A prospective analysis of 1000 procedures. Acta Anaesthesiol Scand 2011, 55:835-841.
• [3]Kost KM: Endoscopic percutaneous dilatational tracheotomy: a prospective evaluation of 500 consecutive cases. Laryngoscope 2005, 115:1-30.
• [4]Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968, 28:14-20.
• [5]Holdgaard HO, Pedersen J, Jensen RH, Outzen KE, Midtgaard T, Johansen LV, et al.: Percutaneous dilatational tracheostomy versus conventional surgical tracheostomy. A clinical randomised study. Acta Anaesthesiol Scand 1998, 42:545-550.
• [6]Hazard P, Jones C, Benitone J: Comparative clinical trial of standard operative tracheostomy with percutaneous tracheostomy. Crit Care Med 1991, 19:1018-1024.
• [7]Delaney A, Bagshaw S, Nalos M: Percutaneous dilatational tracheostomy versus surgical tracheostomy in critically ill patients: a systematic review and meta-analysis. Crit Care 2006, 10:R55. BioMed Central Full Text
• [8]Antonelli M, Michetti V, Di Palma A, Conti G, Pennisi MA, Arcangeli A, et al.: Percutaneous translaryngeal versus surgical tracheostomy: A randomized trial with 1-yr double-blind follow-up. Crit Care Med 2005, 33:1015-1020.
• [9]Freeman BD, Isabella K, Cobb JP, Boyle WA III, Schmieg RE Jr, Kolleff MH, et al.: A prospective, randomized study comparing percutaneous with surgical tracheostomy in critically ill patients. Crit Care Med 2001, 29:926-930.
• [10]Kleffmann J, Pahl R, Deinsberger W, Ferbert A, Roth C: Effect of percutaneous tracheostomy on intracerebral pressure and perfusion pressure in patients with acute cerebral dysfunction (TIP Trial): an observational study. Neurocrit Care 2012, 17:85-89.
• [11]Griffiths J, Barber VS, Morgan L, Young JD: Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ 2005, 330:1243.
• [12]Young D, Harrison DA, Cuthbertson BH, Rowan K: Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial. JAMA 2013, 309:2121-2129.
• [13]Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR: Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 1996, 85:39-49.
• [14]Mocco J, Ransom ER, Komotar RJ, Schmidt JM, Sciacca RR, Mayer SA, et al.: Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery 2006, 59:529-538.
• [15]Rondeau N, Cinotti R, Rozec B, Roquilly A, Floch H, Groleau N, et al.: Dobutamine-induced high cardiac index did not prevent vasospasm in subarachnoid hemorrhage patients: a randomized controlled pilot study. Neurocrit Care 2012, 17:183-190.
• [16]Neuschmelting V, Fathi AR, Hidalgo Staub ET, Marbacher S, Schroth G, Takala J, et al.: Norepinephrine-induced hypertension dilates vasospastic basilar artery after subarachnoid haemorrhage in rabbits. Acta Neurochir (Wien) 2009, 151:487-493.
• [17]Meyer R, Deem S, Yanez ND, Souter M, Lam A, Treggiari MM: Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care 2011, 14:24-36.
• [18]Audibert G, Pottie JC, Hummer M, Torrens J: Anesthesia and intensive care of subarachnoid hemorrhage. A survey on practice in 32 centres. Ann Fr Anesth Reanim 1996, 15:338-341.
• [19]Palma JA, Fontes-Villalba A, Irimia P, Garcia-Eulate R, Martinez-Vila E: Reversible cerebral vasoconstriction syndrome induced by adrenaline. Cephalalgia 2012, 32:500-504.
• [20]Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC: Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987, 18:365-372.
• [21]Nieszkowska A, Combes A, Luyt CE, Ksibi H, Trouillet JL, Gibert C, et al.: Impact of tracheotomy on sedative administration, sedation level, and comfort of mechanically ventilated intensive care unit patients. Crit Care Med 2005, 33:2527-2533.
• [22]Veelo D, Dongelmans D, Binnekade J, Korevaar J, Vroom M, Schultz M: Tracheotomy does not affect reducing sedation requirements of patients in intensive care - a retrospective study. Crit Care 2006, 10:R99. BioMed Central Full Text
• [23]Nieuwkamp DJ, Algra A, Blomqvist P, Adami J, Buskens E, Koffijberg H, et al.: Excess Mortality and Cardiovascular Events in Patients Surviving Subarachnoid Hemorrhage: A Nationwide Study in Sweden. Stroke 2011, 42:902-907.
• [24]Samuels O, Webb A, Culler S, Martin K, Barrow D: Impact of a dedicated neurocritical care team in treating patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011, 14:334-340.
• [25]Lindekleiv H, Sandvei MS, Njolstad I, Lochen ML, Romundstad PR, Vatten L, et al.: Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: a cohort study. Neurology 2011, 76:637-643.
• [26]Sandvei MS, Lindekleiv H, Romundstad PR, Muller TB, Vatten LJ, Ingebrigtsen T, et al.: Risk factors for aneurysmal subarachnoid hemorrhage - BMI and serum lipids: 11-year follow-up of the HUNT and the Tromso Study in Norway. Acta Neurol Scand 2012, 125:382-388.